Yale scientists recode the genome for programmable synthetic proteins
On Feb. 6, 2025, a team of synthetic biologists from Yale University announced they have re-written the genetic…
On Feb. 6, 2025, a team of synthetic biologists from Yale University announced they have re-written the genetic…
On Nov. 4, 2024, the U.S. Food and Drug Administration (FDA), in collaboration with the Environmental Protection Agency…
On Oct. 27, 2022, the U.S. Department of Agriculture’s Animal Plant Health Inspection Service (APHIS) confirmed the presence…
On Apr. 29, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Oct. 19, 2021, National Science Foundation funded scientists at the Yale School of Public Health and the…
On Jan. 28, 2021, Precipio announced that following receipt of an Emergency Use Authorization from the U.S. Food…
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
On Oct. 8, 2020, the National Institutes of Health (NIH) awarded a Research Project Cooperative Agreement grant to…
On Oct. 2, 2020, Yale scientists announced construction of the next-generation human brain PET scanner, the NeuroeXplorer (NX),…
On Sept. 24, 2020, Yale University announced it had designated three independent laboratories to perform the university-developed SalivaDirect…
On Apr. 23, 2020, Yale researchers began a clinical trial at Yale New Haven Hospital to test the…
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
On Oct. 29, 2019, the Yale Science Building officially opened as a central hub for interdisciplinary collaboration on…
On Jan. 19, 2018, Yale evolutionary geneticist Gunter Wagner received the 2018 Daniel Giraud Elliot Medal from the…
On Jan. 12, 2018, Connecticut United for Research Excellence Inc. (CURE) renamed itself BioCT and today is the…
In 2018, Rallybio was founded as a privately-held, development-stage biotechnology company focused on bringing life-transforming medicines to patients…
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
In 2015, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research…
On Oct. 21, 2014, the Jackson Laboratory (JAX) announced that technology investor David Roux and his wife Barbara…
On Oct. 7, 2014, The Jackson Laboratory opened a state-of-the-art genomics research center on the campus of the…
On Sept. 28, 2012, the Connecticut Challenge Survivorship Clinic opened at Yale Cancer Center providing — the first…
In 2012, Smilow Cancer Hospital and Yale Cancer Center opened 8 Smilow Cancer Care Centers in Connecticut. Today,…
In 2011, Precipio was founded in New Haven, Connecticut to build a platform designed to eradicate the problem…
On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with María Rosa Menocal, a Yale…
In 2007, West Campus, located on 136 acres 7 miles west of downtown New Haven, was acquired. West…
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
In 2002, digital diagnostic technology was developed with the creation of AQUA (Automated Quantitative Analysis) at Yale Cancer…
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…